WWBP Financials 07/16/2014 03:13:44 Worldwide Bio
Post# of 3
Posted On: 07/16/2014 4:13:41 AM
WWBP Financials 07/16/2014 03:13:44
Worldwide Biotech & Pharmaceutical Co.
Period Ending Dec 31, 2010
Total Revenue 13
Cost of Revenue 138
Gross Profit (125)
Operating Expenses
Research and Development 14
Sales, General and Admin. 688
Non-Recurring Items -
Other -
Operating Income (827)
Income From Continuing Operations
Add'l Income/Expense Items (112)
Earnings Before Interest and Tax (939)
Interest Expense 487
Earnings Before Tax (1,426)
Income Tax -
Minority Interest (286)
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations (1,141)
Non Recurring Events
Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income (1,141)
Preferred Stock and Other Adjustments -
Net Income Applicable to Common Shareholders (1,141)
Worldwide Biotech & Pharmaceutical Co.
Period Ending Dec 31, 2010
Total Revenue 13
Cost of Revenue 138
Gross Profit (125)
Operating Expenses
Research and Development 14
Sales, General and Admin. 688
Non-Recurring Items -
Other -
Operating Income (827)
Income From Continuing Operations
Add'l Income/Expense Items (112)
Earnings Before Interest and Tax (939)
Interest Expense 487
Earnings Before Tax (1,426)
Income Tax -
Minority Interest (286)
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations (1,141)
Non Recurring Events
Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income (1,141)
Preferred Stock and Other Adjustments -
Net Income Applicable to Common Shareholders (1,141)
(0)
(0)Worldwide Bio & Phar (WWBP) Stock Research Links
Scroll down for more posts ▼